See more : Gold Hunter Resources Inc. (HUNT.CN) Income Statement Analysis – Financial Results
Complete financial analysis of Brooks Laboratories Limited (BROOKS.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Brooks Laboratories Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Sprott Inc. (SII) Income Statement Analysis – Financial Results
- Gujarat State Fertilizers & Chemicals Limited (GSFC.NS) Income Statement Analysis – Financial Results
- Advanced Ceramic X Corporation (3152.TWO) Income Statement Analysis – Financial Results
- Sealmatic India Limited (SEALMATIC.BO) Income Statement Analysis – Financial Results
- Perion Network Ltd. (PERI.TA) Income Statement Analysis – Financial Results
Brooks Laboratories Limited (BROOKS.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.brookslabs.net
About Brooks Laboratories Limited
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. It offers liquid and dry powder injection, carbapenem drugs, tablets, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 794.86M | 624.81M | 900.93M | 770.40M | 691.33M | 550.30M | 557.12M | 575.40M | 800.09M | 852.13M | 852.69M | 801.13M | 560.76M | 525.39M | 450.68M | 449.26M | 281.65M |
| Cost of Revenue | 729.24M | 612.21M | 757.99M | 552.40M | 534.77M | 454.47M | 466.81M | 396.07M | 566.06M | 651.32M | 627.75M | 596.35M | 384.87M | 391.94M | 351.30M | 368.79M | 205.67M |
| Gross Profit | 65.62M | 12.60M | 142.95M | 218.00M | 156.56M | 95.83M | 90.30M | 179.33M | 234.04M | 200.81M | 224.94M | 204.77M | 175.88M | 133.45M | 99.38M | 80.47M | 75.98M |
| Gross Profit Ratio | 8.26% | 2.02% | 15.87% | 28.30% | 22.65% | 17.41% | 16.21% | 31.17% | 29.25% | 23.57% | 26.38% | 25.56% | 31.37% | 25.40% | 22.05% | 17.91% | 26.98% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 43.71M | 100.88M | 88.40M | 65.54M | 43.75M | 43.22M | 42.93M | 34.82M | 4.70M | 3.86M | 104.45M | 27.27M | 21.82M | 14.97M | 20.79M | 20.58M | 18.99M |
| Selling & Marketing | 2.45M | 3.43M | 2.60M | 2.57M | 6.47M | 4.85M | 7.40M | 4.80M | 29.07M | 57.21M | 86.86M | 55.06M | 22.14M | 1.83M | 4.85M | 2.77M | 2.45M |
| SG&A | 46.15M | 104.31M | 91.00M | 68.11M | 50.22M | 48.07M | 50.33M | 39.62M | 33.77M | 61.07M | 104.45M | 82.33M | 43.97M | 16.79M | 25.64M | 23.35M | 21.44M |
| Other Expenses | 0.00 | 1.07M | 1.35M | 5.63M | 332.00K | 1.20M | 965.00K | 117.00K | 1.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 51.18M | 348.09M | 359.97M | 284.00M | 249.00M | 216.88M | 244.00M | 145.64M | 131.70M | 139.32M | 148.03M | 107.80M | 77.61M | 46.37M | 30.68M | 27.30M | 25.28M |
| Cost & Expenses | 780.42M | 960.30M | 1.12B | 836.40M | 783.77M | 671.35M | 710.82M | 541.70M | 697.76M | 790.65M | 775.78M | 704.16M | 462.49M | 438.31M | 381.99M | 396.09M | 230.95M |
| Interest Income | 736.00K | 921.00K | 877.00K | 1.69M | 1.51M | 1.08M | 1.35M | 1.08M | 13.91M | 23.27M | 963.00 | 0.00 | 9.00M | 824.84K | 8.75K | -52.00 | -13.00 |
| Interest Expense | 8.45M | 19.54M | 28.31M | 30.98M | 33.50M | 29.63M | 24.04M | 8.77M | 7.49M | 2.11M | 856.00K | 0.00 | 15.36M | 16.08M | 15.19M | 21.12M | 11.45M |
| Depreciation & Amortization | 17.73M | 70.27M | 73.51M | 71.43M | 66.48M | 65.00M | 64.45M | 16.72M | 11.60M | 11.04M | 8.32M | 8.14M | 6.56M | 6.11M | 5.19M | 4.37M | 3.88M |
| EBITDA | 41.73M | -291.68M | -134.50M | 12.52M | -35.16M | -54.86M | -86.85M | 50.42M | 113.23M | 68.61M | 85.24M | 104.71M | 113.62M | 93.19M | 75.09M | 57.54M | 54.58M |
| EBITDA Ratio | 5.25% | -47.86% | -15.73% | 1.66% | -3.48% | -9.77% | -15.59% | 8.74% | 15.83% | 11.01% | 9.96% | 13.12% | 18.69% | 17.94% | 16.39% | 12.81% | 19.38% |
| Operating Income | 14.44M | -338.45M | -218.62M | -108.43M | -95.10M | -148.59M | -153.70M | 30.61M | 108.19M | 103.50M | 75.72M | 95.83M | 91.70M | 71.90M | 54.90M | 32.05M | 39.22M |
| Operating Income Ratio | 1.82% | -54.17% | -24.27% | -14.07% | -13.76% | -27.00% | -27.59% | 5.32% | 13.52% | 12.15% | 8.88% | 11.96% | 16.35% | 13.68% | 12.18% | 7.13% | 13.93% |
| Total Other Income/Expenses | -210.10M | 26.64M | -20.36M | -230.20M | -40.04M | -28.43M | -21.64M | -8.87M | -83.61M | -76.88M | -9.53M | -1.08M | -7.98M | -14.74M | -13.56M | -20.44M | -10.69M |
| Income Before Tax | -195.66M | -383.78M | -238.98M | -89.85M | -135.14M | -149.48M | -175.34M | 24.83M | 108.19M | 103.50M | 75.72M | 95.83M | 91.70M | 71.90M | 54.90M | 32.05M | 39.22M |
| Income Before Tax Ratio | -24.62% | -61.42% | -26.53% | -11.66% | -19.55% | -27.16% | -31.47% | 4.32% | 13.52% | 12.15% | 8.88% | 11.96% | 16.35% | 13.68% | 12.18% | 7.13% | 13.93% |
| Income Tax Expense | 259.00K | -73.24M | -45.85M | 103.82M | 108.62M | -1.43M | -37.21M | 8.16M | 1.86M | 8.83M | 3.32M | 24.39M | 3.34M | 3.02M | 3.18M | 2.41M | 6.95M |
| Net Income | -195.92M | -310.54M | -193.13M | -193.76M | -243.76M | -148.05M | -138.13M | 16.67M | 106.33M | 94.67M | 72.40M | 71.44M | 88.36M | 68.88M | 51.72M | 29.64M | 32.27M |
| Net Income Ratio | -24.65% | -49.70% | -21.44% | -25.15% | -35.26% | -26.90% | -24.79% | 2.90% | 13.29% | 11.11% | 8.49% | 8.92% | 15.76% | 13.11% | 11.48% | 6.60% | 11.46% |
| EPS | -7.67 | -12.45 | -7.74 | -7.77 | -13.71 | -7.37 | -7.05 | 0.85 | 5.43 | 4.83 | 3.69 | 3.64 | 4.51 | 5.76 | 9.18 | 9.47 | 2.71 |
| EPS Diluted | -7.65 | -12.45 | -7.74 | -7.77 | -13.71 | -7.37 | -7.05 | 0.85 | 5.43 | 4.83 | 3.69 | 3.64 | 4.51 | 5.76 | 4.36 | 9.47 | 2.71 |
| Weighted Avg Shares Out | 25.54M | 24.94M | 24.94M | 24.94M | 17.78M | 20.10M | 19.60M | 19.60M | 19.60M | 19.60M | 19.60M | 19.60M | 19.60M | 11.90M | 5.63M | 3.13M | 11.90M |
| Weighted Avg Shares Out (Dil) | 25.62M | 24.94M | 24.94M | 24.94M | 17.78M | 20.10M | 19.60M | 19.60M | 19.60M | 19.60M | 19.60M | 19.60M | 19.60M | 11.90M | 11.87M | 3.13M | 11.90M |
No news found for: BROOKS.BO
Source: https://incomestatements.info
Category: Stock Reports